Journal article
Antiplatelet regimens following carotid artery revascularization
The American heart journal, Vol.253, pp.48-52
11/2022
DOI: 10.1016/j.ahj.2022.07.004
PMID: 35863439
Abstract
Dual antiplatelet therapy (DAPT) is indicated following carotid artery stenting (CAS) and single antiplatelet therapy (SAPT) following carotid endarterectomy (CEA), but it remains unknown how providers adhere to these guidelines in real-world clinical practice. Using the Vascular Quality Initiative New England data, we found that of 12,257 patients, 82% patients were discharged on DAPT following CAS and 66% were discharged on SAPT following CEA. While a high percentage of patients undergoing CAS appropriately receive DAPT, the use of SAPT following CEA exists with more variability and lower adherence rates.
Details
- Title: Subtitle
- Antiplatelet regimens following carotid artery revascularization
- Creators
- Megan Lee - Yale New Haven Health SystemZain V Ahmed - Yale New Haven Health SystemJiaming Huang - Yale New Haven Health SystemAaron Brice - Yale New Haven Health SystemAhmad Arham - Yale New Haven Health SystemYulanka Castro-Dominguez - Yale New Haven Health SystemEdouard Aboian - Yale New Haven Health SystemSameer Nagpal - Yale New Haven Health SystemKim G Smolderen - Yale New Haven Health SystemCarlos Mena-Hurtado - Yale New Haven Health System
- Resource Type
- Journal article
- Publication Details
- The American heart journal, Vol.253, pp.48-52
- DOI
- 10.1016/j.ahj.2022.07.004
- PMID
- 35863439
- ISSN
- 0002-8703
- eISSN
- 1097-6744
- Language
- English
- Date published
- 11/2022
- Academic Unit
- Internal Medicine
- Record Identifier
- 9985157628702771
Metrics
1 Record Views